Mass Production Service

Revolutionizing Drug Delivery: Collaborative Breakthrough in Dissolving Microneedle Mass Production 

In the rapidly evolving world of drug delivery and skincare, dissolving microneedle technology is emerging as a game-changer. These innovative, pain-free microneedles—designed to dissolve upon application—offer precise delivery of therapeutics, vaccines, and active ingredients. However, transitioning from lab-scale innovation to mass production remains a critical challenge. 

That’s why we’re thrilled to announce our groundbreaking collaboration with a leading CRO/CDMO partner to advance pilot-scale production of dissolving microneedles. This partnership bridges the gap between cutting-edge research and scalable manufacturing, accelerating the journey from concept to patient. 

Why Focus on Dissolving Microneedle Technology? 

Dissolving microneedles combine patient comfort with efficacy, making them ideal for applications like: 

• Vaccine delivery 
• Chronic disease management 
• Cosmetic skincare 
• Biopharmaceuticals 

Key Highlights of the Collaboration 

1. Pilot-Scale Excellence: Our partnership leverages state-of-the-art facilities to optimize processes for high-yield, consistent microneedle production. 
2. End-to-End Expertise: From formulation refinement to regulatory support, our CRO/CDMO collaborator ensures seamless scaling. 
3. Cost-Effective Solutions: Advanced manufacturing techniques reduce waste and lower per-unit costs, enabling accessible pricing. 
4. Speed to Market: Agile pilot-scale workflows slash development timelines, ensuring faster commercialization. 

Collaborating with a Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO) unlocks: 

1. Technical Mastery: Decades of experience in biomaterials and transdermal systems. 
2. Regulatory Navigation: Compliance with FDA, EMA, and global standards. 
3. Scalable Infrastructure: Facilities equipped for pilot batches through full-scale manufacturing. 

This collaboration isn’t just about producing microneedles—it’s about redefining how therapies reach the world. Whether you’re developing a novel vaccine, a cosmeceutical, or a targeted biologic, our dissolving microneedle technology and mass production expertise can transform your vision into reality. 

Ready to scale your innovation? Let’s discuss how our pilot-scale capabilities and CRO/CDMO partnership can accelerate your project. 

Contact us today to explore collaboration opportunities!